Clinical Trials Directory

Trials / Unknown

UnknownNCT03531515

Predictors of Reactive Thrombocytosis in Critically Ill Septic Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Reactive or secondary thrombocytosis is defined as abnormally high platelet count (≥4,50,000 platelets per micro-liter) in the absence of chronic myeloproliferative disease. In critically ill patients reactive thrombocytosis is not uncommon during recovery phase and an association has been seen with poor outcome and increased risk of subsequent VTE. However, not all patients with infection respond with thrombocytosis. No study has enumerated the risk factors or predictors of reactive thrombocytosis in critically ill septic patients.

Detailed description

All patients admitted to intensive care unit of the department of Critical Care Medicine during one year period will be screened for possible inclusion in this study. In this prospective observational study, demographic and clinical characteristics of all ICU patients who fulfill inclusion criteria will be collected along with relevant laboratory tests done for patient management routinely. ICU prognostication scores, i.e., Acute Physiologic and Chronic Health Evaluation (APACHE) II score and Sequential Organ Failure Assessment (SOFA) score will also be recorded. ICU survivors will be followed up in their routine ICU follow up clinic visits. Sample size was estimated at 10% incidence rate of reactive thrombocytes, two sided 95% confidence interval and 4.5% margin of error of the incidence rate, sample size came out to be 171. Finally in this study investigators have targeted to include at least 180 participants. Sample size was estimated using software power analysis and sample size, 2008 (PASS-8).

Conditions

Timeline

Start date
2018-04-11
Primary completion
2019-04-01
Completion
2019-04-01
First posted
2018-05-21
Last updated
2018-05-21

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03531515. Inclusion in this directory is not an endorsement.